| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa1f97d963ba8d6d4c8acc88be41cbb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd8f317227a4a560638b6437aa707447
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2434946a393ffbac0f371a7e81da5ab6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18939a4c9de19b39d5eaa74033a6f56b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-42 |
| filingDate |
2010-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1133df82b5f117e39b27152ed3aba809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d261e73253a0613c83e5ca9dcb2c8af2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_153a9916ef381c87865c529685d13dff |
| publicationDate |
2012-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8173670-B2 |
| titleOfInvention |
Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids |
| abstract |
A method for treating a subject having an inflammatory or auto-immune disease with a substituted isoxazolo pyridinone. Also, a method for administering a substituted isoxazolo pyridinone to a cell to retain or increase glucocorticoid receptor transrepression activity with only minimal glucocorticoid receptor transactivation activity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9975918-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10954265-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015048316-A1 |
| priorityDate |
2009-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |